0001209191-21-061296.txt : 20211021 0001209191-21-061296.hdr.sgml : 20211021 20211021183215 ACCESSION NUMBER: 0001209191-21-061296 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211019 FILED AS OF DATE: 20211021 DATE AS OF CHANGE: 20211021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jansen Valerie Malyvanh CENTRAL INDEX KEY: 0001889716 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40523 FILM NUMBER: 211338195 MAIL ADDRESS: STREET 1: C/O ELEVATION ONCOLOGY, INC. STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-19 0 0001783032 Elevation Oncology, Inc. ELEV 0001889716 Jansen Valerie Malyvanh C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 0 1 0 0 Chief Medical Officer Employee Stock Option (Right to Buy) 7.58 2021-10-19 4 A 0 40000 0.00 A 2031-10-18 Common Stock 40000 40000 D The stock option vests as to 25% of the total shares on October 19, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Joseph Ferra, Attorney-in-Fact 2021-10-21